ALV
0.07
250%
LUX
0.225
-38.4%
PMM
0.31
72.2%
MGH
4.63
-34%
EDE
0.086
59.3%
KRR
0.055
-29.5%
DAL
0.115
53.3%
WBT
2.8
-28.8%
LIO
0.018
38.5%
EXR
0.056
-28.2%
NOR
0.022
37.5%
CQT
0.011
-26.7%
LKO
0.34
33.3%
AAU
0.006
-25%
REC
0.044
33.3%
BNL
0.003
-25%
CRR
0.009
28.6%
AEG
0.05
-23.1%
CYP
0.014
27.3%
MHK
0.1
-23.1%
KZR
0.175
25%
EM3
0.085
-22.7%
PSC
0.3
25%
WMG
0.125
-21.9%
VBC
0.23
24.3%
ELS
4.13
-21.8%
NMD
0.36
24.1%
BST
0.225
-21.1%
EMA
0.052
23.8%
EGR
0.23
-20.7%
BKY
0.61
23.2%
TER
0.063
-20.3%
LGI
2.34
20.3%
SKS
8.75
-20.1%
IPD
0.006
20%
BLU
0.004
-20%
WRX
0.048
20%
CDE
0.004
-20%
TAS
0.031
19.2%
SRJ
0.004
-20%
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Vitrafy Life Sciences (ASX:VFY): Lists on ASX

Vitrafy Life Sciences has listed on the ASX with a ticker code of VFY. The company has designed and developed an innovative cryopreservation solution, which has application across many uses in animal and human health. Having proven its technology, Vitrafy is now pursuing additional product development initiatives and collaboration agreements.

Website: https://vitrafy.com/
Board: Sonia Petering – Chair, Assoc Professor John McBain – Chair, Scientific Advisory Board and Non-Executive Director, Brent Owens – Deputy Chief Executive Officer, Co-Founder and Executive Director, Kate Munnings – Chief Executive Officer, Vaughan Webber – Non‑Executive Director
Management: Kate Munnings – Chief Executive Officer, Simon Martin – Chief Financial Officer
Media: The Stock Network Lel Smits